Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

SG Hiscock and Co portfolio manager Hamish Tadgell is an unrepentant active value manager in an era of passive money.

Health insurance companies, including CVS Caremark, are altering coverage for GLP-1 weight loss medications like Zepbound, ...

When looking for a high-protein snack that supports gut health, there are some snacks that check both of those boxes. When we ...

A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study ...

Weight-loss supplements recommended by influencers on social mead are generally ineffective for weight loss, but do have some benefits.

Retirees looking for dividend growth stocks at a reasonable price have ample reasons to look outside of America, especially ...

For more health information, please see recent studies about Vitamin D that may reduce dangerous complications in diabetes ...

Gov. Maura Healey signed the new fiscal year's $61 billion operating plan on Friday, marking the earliest the state has ...

GLP-1 weight loss patches are everywhere but do they actually work as these trendy patches promise Ozempic-like results ...

MariTide, a new drug from Amgen, helped some people with obesity lose up to 20% of their body weight. In a phase 2 trial, a new GLP-1 drug helped people lose up to 20% of their body weight over a year ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.